Cargando…
Current opinion and mechanistic interpretation of combination therapy for castration-resistant prostate cancer
Recent advances in genomics technology have led to the massive discovery of new drug targets for prostate cancer; however, none of the currently available therapeutics is curative. One of the greatest challenges is drug resistance. Combinations of therapies with distinct mechanisms of action represe...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498727/ https://www.ncbi.nlm.nih.gov/pubmed/30924449 http://dx.doi.org/10.4103/aja.aja_10_19 |